{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:38:52Z","timestamp":1791394732983,"version":"4.3.3"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["106556"],"award-info":[{"award-number":["106556"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00455","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T09:17:17Z","timestamp":1529399837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":411,"title":["On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicolas","family":"Gigu\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Burke Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Eric","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. (1817)","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson's disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp Neurol."},{"key":"B4","first-page":"920","article-title":"Paralysis agitans","volume-title":"Handbuch der Neurologie, hsg. von Max Lewandowsky, Dritter Band, Spezielle Neurologie II. F\u00fcr Sp\u00e4ter Vormerken","author":"Lewy","year":"1912"},{"key":"B5","volume-title":"Contribution a l'Etude de l'Anatomiepathologique du Locus Niger de Soemmering Avec Quelques Deductions Relatives a la Pathologenie des Troubles Dutonus Musculaire de Lamaladiede Parkinson, th\u00e8se","author":"Tretiakoff","year":"1919"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/JPD-179001","article-title":"Neuropathological staging of brain pathology in sporadic Parkinson's disease: Separating the wheat from the Chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/ncomms6659","article-title":"The role of protein clearance mechanisms in organismal ageing and age-related diseases","volume":"5","author":"Vilchez","year":"2014","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.brainres.2016.04.042","article-title":"ER stress and Parkinson's disease: pathological inputs that converge into the secretory pathway","volume":"1648","author":"Mercado","year":"2016","journal-title":"Brain Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/15548627.2015.1121360","article-title":"Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders","volume":"12","author":"Cai","year":"2016","journal-title":"Autophagy."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JPD-160989","article-title":"PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?","volume":"7","author":"Truban","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","author":"Bose","year":"2016","journal-title":"J Neurochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease","volume":"147","author":"Jiang","year":"2016"},{"key":"B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","article-title":"The potential role of neuroinflammation and transcription factors in Parkinson disease","volume":"19","author":"Tiwari","year":"2017","journal-title":"Dialogues Clin Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jnr.24185","article-title":"Updates on immunity and inflammation in Parkinson disease pathology","volume":"96","author":"Joshi","year":"2017","journal-title":"J Neurosci Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jnc.13572","article-title":"Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease","author":"Duda","year":"2016","journal-title":"J Neurochem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson's disease","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2002","journal-title":"Neurobiol Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","article-title":"Lewy body pathology in normal elderly subjects","volume":"68","author":"Markesbery","year":"2009","journal-title":"J Neuropathol Exp Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1212\/01.WNL.0000134657.25904.0B","article-title":"Parkin-positive autosomal recessive juvenile Parkinsonism with \u03b1-synuclein-positive inclusions","volume":"63","author":"Sasaki","year":"2004","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8","article-title":"An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene","volume":"15","author":"Hayashi","year":"2000","journal-title":"Mov Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.22588","article-title":"Nigral pathology and parkinsonian signs in elders without Parkinson disease","volume":"71","author":"Buchman","year":"2012","journal-title":"Ann Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2990.2002.00393.x","article-title":"Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy","volume":"28","author":"Cabello","year":"2002","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog Neurobiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1365-2990.1999.00202.x","article-title":"Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing","volume":"25","author":"Ma","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0047-6374(99)00064-0","article-title":"Cell death of dopamine neurons in aging and Parkinson's disease","volume":"111","author":"Naoi","year":"1999","journal-title":"Mech Ageing Dev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-008-0352-8","article-title":"Morphometry of the human substantia nigra in ageing and Parkinson's disease","volume":"115","author":"Rudow","year":"2008","journal-title":"Acta neuropathologica"},{"key":"B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00441-004-0972-9","article-title":"Histological changes of the dopaminergic nigrostriatal system in aging","volume":"318","author":"Stark","year":"2004","journal-title":"Cell Tissue Res"},{"key":"B37","first-page":"201","article-title":"Age, environments, and the number of substantia nigra neurons","volume":"53","author":"Thiessen","year":"1990","journal-title":"Adv Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0304-3940(00)01244-1","article-title":"Age-related changes of neuronal counts in the human pedunculopontine nucleus","volume":"288","author":"Ransmayr","year":"2000","journal-title":"Neurosci Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1600-0447.1988.tb05189.x","article-title":"Locus ceruleus morphometry in aging and schizophrenia","volume":"77","author":"Lohr","year":"1988","journal-title":"Acta Psychiatr Scand."},{"key":"B40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2463\/mrms.5.197","article-title":"Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla","volume":"5","author":"Shibata","year":"2006","journal-title":"Magn Reson Med Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.3949\/ccjm.76.s2.10","article-title":"Cardiac denervation in patients with Parkinson disease","author":"Goldstein","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"B42","unstructured":"Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET2407 WongKK RaffelDM KoeppeRA FreyKA BohnenNI GilmanS 10.1148\/radiol.1211272322843766Radiology2652012"},{"key":"B43","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","article-title":"The brain-stem lesions in Parkinsonism","volume":"16","author":"Greenfield","year":"1953","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/BF00686528","article-title":"The number of nerve cells in the substantia nigra in paralysis agitans","volume":"5","author":"Pakkenberg","year":"1965","journal-title":"Acta Neuropathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/jnnp.39.11.1092","article-title":"Dysautonomia in Parkinsonism: a clinicopathological study","volume":"39","author":"Rajput","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00695605","article-title":"Dementia in idiopathic Parkinson's disease","volume":"64","author":"Gaspar","year":"1984","journal-title":"Acta Neuropathol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0404.1984.tb00798.x","article-title":"The basal nucleus of Meynert in idiopathic Parkinson's disease","volume":"70","author":"Tagliavini","year":"1984","journal-title":"Acta Neurol Scandinav"},{"key":"B50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/cne.902730409","article-title":"Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia","volume":"273","author":"Chan-Palay","year":"1988","journal-title":"J Comp Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/WNL.38.9.1402","article-title":"A comparison of clinical and pathological features of young- and old-onset Parkinson's disease","volume":"38","author":"Gibb","year":"1988","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ana.410260403","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization","volume":"26","author":"German","year":"1989","journal-title":"Ann Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.410260107","article-title":"Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra","volume":"26","author":"Rinne","year":"1989","journal-title":"Ann Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.410260106","article-title":"The pedunculopontine nucleus in Parkinson's disease","volume":"26","author":"Zweig","year":"1989","journal-title":"Ann Neurol"},{"key":"B56","first-page":"31","article-title":"The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability","volume":"53","author":"Gibb","year":"1990","journal-title":"Adv Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"key":"B60","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/brain\/114.3.1363","article-title":"Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease","volume":"114","author":"Xuereb","year":"1991","journal-title":"Brain"},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-0404.1992.tb05036.x","article-title":"Mean volume of pigmented neurons in the substantia nigra in Parkinson's disease","volume":"137","author":"Moller","year":"1992","journal-title":"Acta Neurol Scand Suppl"},{"key":"B62","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1212\/WNL.43.5.986","article-title":"The locus ceruleus and dementia in Parkinson's disease","volume":"43","author":"Zweig","year":"1993","journal-title":"Neurology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0006-8993(94)90511-8","article-title":"Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?","volume":"668","author":"Mouatt-Prigent","year":"1994","journal-title":"Brain Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2990.1995.tb01023.x","article-title":"Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls","volume":"21","author":"Ma","year":"1995","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0967-5868(96)90083-1","article-title":"Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease","volume":"3","author":"Halliday","year":"1996","journal-title":"J Clin Neurosci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0022-510X(96)00069-X","article-title":"A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease","volume":"140","author":"Ma","year":"1996","journal-title":"J Neurol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-510X(97)00100-7","article-title":"Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts","volume":"151","author":"Ma","year":"1997","journal-title":"J Neurol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/1531\u20138249(200003)47:3<345::AID-ANA10>3.0.CO","article-title":"Degeneration of the centre median-parafascicular complex in Parkinson's disease","volume":"47","author":"Henderson","year":"2000","journal-title":"Ann Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in alzheimer and Parkinson diseases","volume":"60","author":"Zarrow","year":"2003","journal-title":"Arch Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","article-title":"Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra","volume":"63","author":"Greffard","year":"2006","journal-title":"Arch Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/mds.25952","article-title":"Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease","volume":"29","author":"Dijkstra","year":"2014","journal-title":"Mov Disord"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/mds.25975","article-title":"Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts","volume":"29","author":"Kraemmer","year":"2014","journal-title":"Mov Disord"},{"key":"B78","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mds.26144","article-title":"Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias","volume":"30","author":"Cheshire","year":"2015","journal-title":"Mov Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0000000000002102","article-title":"Parkinson disease and incidental Lewy body disease: Just a question of time?","volume":"85","author":"Iacono","year":"2015","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J Comp Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/brain\/114.5.2253","article-title":"Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease","volume":"114","author":"Gai","year":"1991","journal-title":"Brain"},{"key":"B82","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2990.1993.tb00480.x","article-title":"A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease","volume":"19","author":"Patt","year":"1993","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/brain\/118.1.131","article-title":"Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis","volume":"118","author":"Hoogendijk","year":"1995","journal-title":"Brain"},{"key":"B85","first-page":"80","article-title":"Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease","volume":"35","author":"Bertrand","year":"1997","journal-title":"Folia Neuropathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5414\/NPP30104","article-title":"Differential degeneration of the locus coeruleus in dementia subtypes","volume":"30","author":"Brunnstrom","year":"2011","journal-title":"Clin Neuropathol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainres.2010.12.015","article-title":"Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease","volume":"1373","author":"McMillan","year":"2011","journal-title":"Brain Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2990.2011.01203.x","article-title":"Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder","volume":"38","author":"Dugger","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia","volume":"84","author":"Del","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","article-title":"Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases","volume":"59","author":"Candy","year":"1983","journal-title":"J Neurol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ana.410130118","article-title":"Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam","volume":"13","author":"Nakano","year":"1983","journal-title":"Ann Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Ann Neurol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410150503","article-title":"Parkinson's disease: Neuron loss in the nucleus basalis withouth concomitant Alzheimer's Disease","volume":"15","author":"Nakano","year":"1984","journal-title":"Ann Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ana.410170210","article-title":"The nucleus basalis of Meynert in neurological disease: a quantitative morphological study","volume":"17","author":"Rogers","year":"1985","journal-title":"Ann Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","article-title":"Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy","volume":"84","author":"Hirsch","year":"1987","journal-title":"Proc Natl Acad Sci USA."},{"key":"B98","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","article-title":"The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease","volume":"51","author":"Jellinger","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.parkreldis.2008.01.006","article-title":"Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients","volume":"14","author":"Rinne","year":"2008","journal-title":"Parkinsonism Related Disord"},{"key":"B100","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1212\/01.wnl.0000298691.71637.96","article-title":"Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy","volume":"70","author":"Schmeichel","year":"2008","journal-title":"Neurology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/NEN.0000000000000014","article-title":"Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients","volume":"72","author":"Hepp","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ajpath.2013.09.002","article-title":"Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease","volume":"183","author":"Pienaar","year":"2013","journal-title":"Am J Pathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0079-6123(08)64576-8","article-title":"The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases","volume":"93","author":"Kremer","year":"1992","journal-title":"Prog Brain Res."},{"key":"B104","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.870080310","article-title":"Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?","volume":"8","author":"Kremer","year":"1993","journal-title":"Mov Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.44.1.84","article-title":"Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease","volume":"44","author":"Purba","year":"1994","journal-title":"Neurology"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1212\/WNL.46.6.1693","article-title":"Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy","volume":"46","author":"Nakamura","year":"1996","journal-title":"Neurology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/WNL.49.2.610","article-title":"Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease","volume":"49","author":"Ansorge","year":"1997","journal-title":"Neurology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0006-3223(97)00338-7","article-title":"Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus","volume":"43","author":"Hoogendijk","year":"1998","journal-title":"Biol Psychiatry"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"B111","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/86.4.781","article-title":"The pathology of certain medullary nuclei in parkinsonism","volume":"86","author":"Eadie","year":"1963","journal-title":"Brain"},{"key":"B112","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.410290602","article-title":"Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease","volume":"29","author":"Saper","year":"1991","journal-title":"Ann Neurol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1212\/WNL.42.11.2106","article-title":"Age-related loss of dorsal vagal neurons in Parkinson's disease","volume":"42","author":"Gai","year":"1992","journal-title":"Neurology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/01.wnl.0000196638.98781.bb","article-title":"Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease","volume":"66","author":"Benarroch","year":"2006","journal-title":"Neurology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/BF00687815","article-title":"Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam","volume":"67","author":"Yamamoto","year":"1985","journal-title":"Acta Neuropathol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00401-007-0260-3","article-title":"Rostral raphe involvement in Lewy body dementia and multiple system atrophy","volume":"114","author":"Benarroch","year":"2007","journal-title":"Acta Neuropathol"},{"key":"B118","first-page":"189","article-title":"Biochemical neuropathology of Parkinson's disease","volume":"40","author":"Javoy-Agid","year":"1984","journal-title":"Adv Neurol"},{"key":"B119","first-page":"102","article-title":"Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson's disease","volume":"34","author":"Dymecki","year":"1996","journal-title":"Folia Neuropathol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/exnr.1997.6418","article-title":"Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease","volume":"144","author":"McRitchie","year":"1997","journal-title":"Exp Neurol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.870100309","article-title":"The anterior olfactory nucleus in Parkinson's disease","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov Disord"},{"key":"B122","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/mds.10713","article-title":"A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease","volume":"19","author":"Huisman","year":"2004","journal-title":"Mov Disord"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/mds.22009","article-title":"Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients","volume":"23","author":"Huisman","year":"2008","journal-title":"Mov Disord"},{"key":"B124","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundinano","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/brain\/123.7.1410","article-title":"Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications","volume":"123","author":"Henderson","year":"2000","journal-title":"Brain"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1093\/brain\/awh596","article-title":"A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease","volume":"128","author":"Halliday","year":"2005","journal-title":"Brain"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson's disease","author":"Wakabayashi","year":"1997","journal-title":"Eur Neurol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mds.20289","article-title":"No global loss of neocortical neurons in Parkinson's disease: a quantitative stereological study","volume":"20","author":"Pedersen","year":"2005","journal-title":"Mov Disord"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/mds.10258","article-title":"Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease","volume":"17","author":"MacDonald","year":"2002","journal-title":"Mov Disord"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"B131","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/hipo.20212","article-title":"Hippocampal neuron and glial cell numbers in Parkinson's disease\u2013a stereological study","volume":"16","author":"Joelving","year":"2006","journal-title":"Hippocampus"},{"key":"B132","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease\u2013the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"B135","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: Why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov Disord"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","article-title":"Calcium and Parkinson's disease","volume":"483","author":"Surmeier","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson's disease","volume":"129","author":"Segura-Aguilar","year":"2014","journal-title":"J Neurochem"},{"key":"B140","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","article-title":"Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells","volume":"34","author":"Van","year":"2009","journal-title":"Neurobiol Dis"},{"key":"B141","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO","article-title":"Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase","volume":"54","author":"Xu","year":"1998","journal-title":"J Neurosci Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1046\/j.1471-4159.2001.00125.x","article-title":"Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter","volume":"76","author":"Whitehead","year":"2001","journal-title":"J Neurochem"},{"key":"B143","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"B144","doi-asserted-by":"publisher","first-page":"9977","DOI":"10.1073\/pnas.1402134111","article-title":"Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo","volume":"111","author":"Lohr","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B145","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1523\/JNEUROSCI.5456-13.2014","article-title":"Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum","volume":"34","author":"Pifl","year":"2014","journal-title":"J Neurosci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J Neurosci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12035-009-8059-y","article-title":"Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons","volume":"39","author":"Guillot","year":"2009","journal-title":"Mol Neurobiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"iv37","DOI":"10.1007\/s00415-005-4008-5","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease?","author":"Fahn","year":"2005","journal-title":"J Neurol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","article-title":"L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?","volume":"94","author":"Lipski","year":"2011","journal-title":"Prog Neurobiol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jmri.22293","article-title":"Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults","volume":"32","author":"Haacke","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"B151","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroimage.2012.12.040","article-title":"Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis","volume":"70","author":"Daugherty","year":"2013","journal-title":"Neuroimage"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.neuroimage.2011.08.077","article-title":"MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping","volume":"59","author":"Bilgic","year":"2012","journal-title":"Neuroimage"},{"key":"B153","doi-asserted-by":"publisher","first-page":"34105","DOI":"10.1074\/jbc.M503483200","article-title":"Selective vulnerability of dopaminergic neurons to microtubule depolymerization","volume":"280","author":"Ren","year":"2005","journal-title":"J Biol Chem"},{"key":"B154","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0072-9752(07)83023-5","article-title":"Iron as a trigger of neurodegeneration in Parkinson's disease","volume":"83","author":"Friedman","year":"2007","journal-title":"Handb Clin Neurol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson's disease","volume":"118","author":"Sian-Hulsmann","year":"2011","journal-title":"J Neurochem"},{"key":"B156","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-005-0914-9","article-title":"MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease","volume":"253","author":"Kosta","year":"2006","journal-title":"J Neurol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0306-4522(96)00047-4","article-title":"Interaction of neuromelanin and iron in substantia nigra and other areas of human brain","volume":"73","author":"Zecca","year":"1996","journal-title":"Neuroscience"},{"key":"B158","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00702-006-0453-2","article-title":"Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability","volume":"113","author":"Zucca","year":"2006","journal-title":"J Neural Transm"},{"key":"B159","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","article-title":"The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging","volume":"101","author":"Zecca","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B160","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1471-4159.2006.04424.x","article-title":"Role of activity-dependent mechanisms in the control of dopaminergic neuron survival","volume":"101","author":"Michel","year":"2007","journal-title":"J Neurochem"},{"key":"B161","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nn.3209","article-title":"Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease","volume":"15","author":"Goldberg","year":"2012","journal-title":"Nat Neurosci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nn.3717","article-title":"Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase","volume":"17","author":"Sanchez-Padilla","year":"2014","journal-title":"Nat Neurosci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1083\/jcb.123.4.949","article-title":"Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits","volume":"123","author":"Hell","year":"1993","journal-title":"J Cell Biol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12031-014-0410-8","article-title":"Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization","volume":"55","author":"Hurley","year":"2015","journal-title":"J Mol Neurosci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/nn.3185","article-title":"K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration","volume":"15","author":"Schiemann","year":"2012","journal-title":"Nat Neurosci"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/nn1570","article-title":"K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons","volume":"8","author":"Liss","year":"2005","journal-title":"Nat Neurosci"},{"key":"B169","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","article-title":"The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease","volume":"7","author":"Pissadaki","year":"2013","journal-title":"Front Comput Neurosci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/(SICI)1096-9861(19960729)371:3<345::AID-CNE1>3.0.CO;2-2","article-title":"Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling","volume":"371","author":"Takakusaki","year":"1996","journal-title":"J Comp Neurol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1096-9861(19971215)389:2<309::AID-CNE9>3.0.CO;2-5","article-title":"Somatodendritic and axonal anatomy of intracellularly labeled serotonergic neurons in the rat medulla","volume":"389","author":"Gao","year":"1997","journal-title":"J Comp Neurol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2009.07.024","article-title":"Morphological and electrophysiological features of motor neurons and putative interneurons in the dorsal vagal complex of rats and mice","volume":"1291","author":"Gao","year":"2009","journal-title":"Brain Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"e87709","DOI":"10.1371\/journal.pone.0087709","article-title":"Distribution of VGLUT3 in highly collateralized axons from the rat dorsal raphe nucleus as revealed by single-neuron reconstructions","volume":"9","author":"Gagnon","year":"2014","journal-title":"PLoS ONE."},{"key":"B175","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0306-4522(89)90210-8","article-title":"An ultrastructural analysis of serotoninergic neurons in the nucleus raphe magnus of the rat","volume":"33","author":"Chazal","year":"1989","journal-title":"Neuroscience"},{"key":"B176","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/cne.902420105","article-title":"The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat","volume":"242","author":"Jones","year":"1985","journal-title":"J Comp Neurol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0306-4522(95)00507-2","article-title":"Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum","volume":"71","author":"Contant","year":"1996","journal-title":"Neuroscience"},{"key":"B178","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/neu.10150","article-title":"Cholinergic interneuron characteristics and nicotinic properties in the striatum","volume":"53","author":"Zhou","year":"2002","journal-title":"J Neurobiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neulet.2010.10.017","article-title":"Measurements of neuron soma size and density in rat dorsal striatum, nucleus accumbens core and nucleus accumbens shell: differences between striatal region and brain hemisphere, but not sex","volume":"487","author":"Meitzen","year":"2011","journal-title":"Neurosci Lett"},{"key":"B180","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J Neural Transm."},{"key":"B182","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci Lett"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-150769","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"B184","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5607\/en.2010.19.3.115","article-title":"The role of axonopathy in Parkinson's disease","volume":"19","author":"O'Malley","year":"2010","journal-title":"Exp Neurobiol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/1673-5374.202934","article-title":"The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease","volume":"12","author":"Kinghorn","year":"2017","journal-title":"Neural Regener Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/mds.26802","article-title":"Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease","volume":"31","author":"Wong","year":"2016","journal-title":"Mov Disord."},{"key":"B187","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","author":"Migdalska-Richards","year":"2016","journal-title":"J Neurochem"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4161\/auto.29074","article-title":"Glucocerebrosidase deficits in sporadic Parkinson disease","volume":"10","author":"Murphy","year":"2014","journal-title":"Autophagy"},{"key":"B191","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov Disord"},{"key":"B192","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/15548627.2014.996021","article-title":"PINK1- and PARK2-mediated local mitophagy in distal neuronal axons","volume":"11","author":"Ashrafi","year":"2015","journal-title":"Autophagy"},{"key":"B193","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell"},{"key":"B194","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neurobiolaging.2012.04.008","article-title":"DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth","volume":"34","author":"Sheng","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B195","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cge.12841","article-title":"DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7","volume":"92","author":"Di","year":"2017","journal-title":"Clin Genet"},{"key":"B196","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial Parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"MacLeod","year":"2006","journal-title":"Neuron"},{"key":"B197","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","article-title":"Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice","volume":"78","author":"Yue","year":"2015","journal-title":"Neurobiol Dis"},{"key":"B198","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2017.08.001","article-title":"Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease","volume":"298","author":"Surmeier","year":"2017","journal-title":"Exp Neurol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2017.03.010","article-title":"Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice","volume":"486","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"B202","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2017.06.009","article-title":"Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant \u03b1-synuclein rat model of parkinsonism","volume":"106","author":"Gleave","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/hmg\/ddx100","article-title":"Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress","volume":"26","author":"Shi","year":"2017","journal-title":"Hum Mol Genet"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T18:09:48Z","timestamp":1604426988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":203,"alternative-id":["10.3389\/fneur.2018.00455"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00455","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"article-number":"455"}}